Use of telemedicine in the diagnosis of paroxysmal atrial fibrillation and to monitor the effect of antiarrhythmic drug therapy.
We present the case of a patient with highly symptomatic tachyarrhythmias for 2 years without any arrhythmia documentation despite numerous ECG and Holter registrations. By means of telemedicine, it was possible to document the arrhythmia--in this case atrial fibrillation--within 10 days and to start antiarrhythmic drug treatment with flecainide and metoprolol. This case demonstrates the diagnostic potential of telemedicine in patients with recurrent episodes of tachyarrhythmias in whom episodes are not sufficiently frequent to allow diagnosis by Holter monitoring. Telemedicine may also be advantageous for ECG monitoring during the early phase after cardioversion or initiation of specific antiarrhythmic pharmacotherapy in order to detect potential drug-induced proarrhythmic changes.
Klingenheben
T
T
Praxis für Kardiologie, Alfred-Bucherer-Strasse 6, 53115 Bonn, Germany. Klingenheben@bonn-kardiologie.de
Israel
C W
CW
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000175:diagnosis*; D015716:Electrocardiography, Ambulatory; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D013614:Tachycardia, Paroxysmal / Q000175:diagnosis*; D013686:Telemetry; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D008790:Metoprolol; D005424:Flecainide